Financials Professional Medical Expertise Company
Equities
9574
SA15RH24LJ13
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.7 SAR | -5.56% | +0.12% | +21.26% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales 1 | 74.42 | 131.3 | 176.1 |
EBITDA 1 | 13.26 | 26.25 | 28.07 |
EBIT 1 | 11.65 | 24.45 | 26.01 |
Operating Margin | 15.65% | 18.63% | 14.77% |
Earnings before Tax (EBT) 1 | 10 | 21.81 | 20.87 |
Net income 1 | 9.296 | 20.62 | 19.02 |
Net margin | 12.49% | 15.71% | 10.8% |
EPS | - | 26.73 | 8.515 |
Free Cash Flow | - | 9.678 | -48.33 |
FCF margin | - | 7.37% | -27.45% |
FCF Conversion (EBITDA) | - | 36.87% | - |
FCF Conversion (Net income) | - | 46.94% | - |
Dividend per Share | - | - | - |
Announcement Date | 6/11/23 | 6/11/23 | 6/11/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | 31.4 | 20.1 | 53.2 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | 2.371 x | 0.7649 x | 1.897 x |
Free Cash Flow | - | 9.68 | -48.3 |
ROE (net income / shareholders' equity) | - | 64.8% | 33.7% |
ROA (Net income/ Total Assets) | - | 10.9% | 8.92% |
Assets 1 | - | 188.9 | 213.1 |
Book Value Per Share | - | 795.0 | 20.90 |
Cash Flow per Share | - | 356.0 | 1.520 |
Capex 1 | 2.06 | 3.34 | 6.51 |
Capex / Sales | 2.77% | 2.54% | 3.7% |
Announcement Date | 6/11/23 | 6/11/23 | 6/11/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+21.26% | 80.79M | |
-3.95% | 184B | |
-0.90% | 109B | |
-2.27% | 68.87B | |
+15.24% | 46.61B | |
-6.00% | 46.39B | |
+5.36% | 40.74B | |
+20.65% | 31.26B | |
-5.50% | 24.24B | |
+11.60% | 24B |
- Stock Market
- Equities
- 9574 Stock
- Financials Professional Medical Expertise Company